Adagio Therapeutics, Inc. carries a market capitalization of 505.68M, placing it among publicly traded companies globally.
| Market Cap | 505.68M |
| Enterprise Value | N/A |
Adagio Therapeutics, Inc.'s stock has declined approximately -27.38654% over the past 52 weeks.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.38654% |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
| Average Volume (20 Days) | N/A |